Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Critical insights into the beneficial and protective actions of the kallikrein–kinin system
D. Regoli, Fernand Gobeil
Vascular Pharmacology (2015) Vol. 64, pp. 1-10
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Unraveling the Pivotal Role of Bradykinin in ACE Inhibitor Activity
Stefano Taddei, Luiz Aparecido Bortolotto
American Journal of Cardiovascular Drugs (2016) Vol. 16, Iss. 5, pp. 309-321
Closed Access | Times Cited: 82
Identification and Molecular Docking Study of a Novel Angiotensin-I Converting Enzyme Inhibitory Peptide Derived from Enzymatic Hydrolysates of Cyclina sinensis
Fangmiao Yu, Zhuangwei Zhang, Liwang Luo, et al.
Marine Drugs (2018) Vol. 16, Iss. 11, pp. 411-411
Open Access | Times Cited: 51
Two novel ACE inhibitory peptides isolated from longan seeds: purification, inhibitory kinetics and mechanisms
Atthasith Nuchprapha, Supawee Paisansak, Papassara Sangtanoo, et al.
RSC Advances (2020) Vol. 10, Iss. 22, pp. 12711-12720
Open Access | Times Cited: 42
Human plasma kallikrein: roles in coagulation, fibrinolysis, inflammation pathways, and beyond
Guacyara Motta, Luiz Juliano, Jair R. Chagas
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 12
A novel angiotensin I-converting enzyme (ACE) inhibitory peptide from Wuyi rock tea residue: preparation, identification, and its potential molecular mechanism
Xiaoliang Cao, Huiyuan Zhou, Jindong Xie, et al.
LWT (2025) Vol. 216, pp. 117353-117353
Open Access
A Phase 1C, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DM199 Administered Intravenously with a Polyvinyl Chloride Bag in Adult Healthy Subjects and Adults Recently Taking Angiotensin‐Converting Enzyme Inhibitors
Michael Giuffre, Annette Lista, Nick B. Paulson, et al.
Clinical Pharmacology in Drug Development (2025)
Open Access
The transient receptor potential ankyrin-1 mediates mechanical hyperalgesia induced by the activation of B1 receptor in mice
Flávia Carla Meotti, Cláudia P. Figueiredo, Marianne N. Manjavachi, et al.
Biochemical Pharmacology (2016) Vol. 125, pp. 75-83
Open Access | Times Cited: 25
Human tissue kallikrein in the treatment of acute ischemic stroke
Michelle Alexander-Curtis, Rick Pauls, Julie Chao, et al.
Therapeutic Advances in Neurological Disorders (2019) Vol. 12
Open Access | Times Cited: 25
Kinins and peptide receptors
D. Regoli, Fernand Gobeil
Biological Chemistry (2015) Vol. 397, Iss. 4, pp. 297-304
Closed Access | Times Cited: 20
Kallikrein–kinin system as the dominant mechanism to counteract hyperactive renin–angiotensin system
D. Regoli, Fernand Gobeil
Canadian Journal of Physiology and Pharmacology (2017) Vol. 95, Iss. 10, pp. 1117-1124
Closed Access | Times Cited: 19
Beneficial effects of kinin B1 receptor antagonism on plasma fatty acid alterations and obesity in Zucker diabetic fatty rats
Sébastien Talbot, Jenny Pena Dias, Adil El Midaoui, et al.
Canadian Journal of Physiology and Pharmacology (2016) Vol. 94, Iss. 7, pp. 752-757
Closed Access | Times Cited: 13
Interplay between the kinin B1 receptor and inducible nitric oxide synthase in insulin resistance
Youssef Haddad, Réjean Couture
British Journal of Pharmacology (2016) Vol. 173, Iss. 12, pp. 1988-2000
Open Access | Times Cited: 13
Cellular localisation of the kinin B1R in the pancreas of streptozotocin-treated rat and the anti-diabetic effect of the antagonist SSR240612
Nejla Tidjane, Louis Gaboury, Réjean Couture
Biological Chemistry (2016) Vol. 397, Iss. 4, pp. 323-336
Closed Access | Times Cited: 13
Role of Matricellular CCN Proteins in Skeletal Muscle: Focus on CCN2/CTGF and Its Regulation by Vasoactive Peptides
Daniela L. Rebolledo, María José Acuña, Enrique Brandan
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5234-5234
Open Access | Times Cited: 12
Novel SNPs of WNK1 and AKR1C3 are associated with preeclampsia
Cheng-Juan Sun, Lin Li, Xueyan Li, et al.
Gene (2018) Vol. 668, pp. 27-32
Closed Access | Times Cited: 13
Decreased plasma kallikrein activity is associated with reduced kidney function in individuals with type 1 diabetes
Mari‐Anne Härma, Emma H. Dahlström, Niina Sandholm, et al.
Diabetologia (2020) Vol. 63, Iss. 7, pp. 1349-1354
Open Access | Times Cited: 12
Peptide fragments of bradykinin show unexpected biological activity not mediated by B1 or B2 receptors
Igor Maciel Souza‐Silva, Cristiane Amorim de Paula, Lucas Bolais‐Ramos, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 12, pp. 3061-3077
Open Access | Times Cited: 8
Development of diabetic macular oedema shows associations with systemic medication – An epidemiological study
Sirpa Loukovaara, Ani Korhonen, Leo Niskanen, et al.
Acta Ophthalmologica (2023) Vol. 102, Iss. 4
Open Access | Times Cited: 4
Kininase 1 As a Preclinical Therapeutic Target for Kinin B1 Receptor in Insulin Resistance
Youssef Haddad, Réjean Couture
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 11
Construction and Application of Membrane-Bound Angiotensin-I Converting Enzyme System: A New Approach for the Evaluation of Angiotensin-I Converting Enzyme Inhibitory Peptides
Chang Liu, Jingbo Liu, Manqiu Wang, et al.
Journal of Agricultural and Food Chemistry (2020) Vol. 68, Iss. 20, pp. 5723-5731
Closed Access | Times Cited: 11
Utero-placental cellular and nuclear expression of bradykinin B2 receptors in normal and preeclamptic pregnancies
Gloría Valdés, Stephanie Maia Acuña, Alejandro Munizaga, et al.
Pregnancy Hypertension (2016) Vol. 6, Iss. 1, pp. 30-37
Closed Access | Times Cited: 10
Imbalance Between Angiotensin II and Kallikrein in Patients With ST-Segment Elevation Myocardial Infarction: A Case-Control Emergency Room Study
Shuhong Dai, Bo Yin, Haiming Wang, et al.
Angiology (2024)
Closed Access | Times Cited: 1
Involvement of the TRPV1 receptor in plasma extravasation in airways of rats treated with an angiotensin-converting enzyme inhibitor
Janiana Raíza Jentsch Matias de Oliveira, Michel Fleith Otuki, Daniela Almeida Cabrini, et al.
Pulmonary Pharmacology & Therapeutics (2016) Vol. 41, pp. 25-33
Closed Access | Times Cited: 9
Difference in the response to angiotensin II between left and right ventricular endocardial endothelial cells
Danielle Jacques, Nelly Abdel-Karim Abdel-Malak, Nadia Abou Abdallah, et al.
Canadian Journal of Physiology and Pharmacology (2017) Vol. 95, Iss. 10, pp. 1271-1282
Closed Access | Times Cited: 7
The kallikrein–kinin system in diabetic kidney disease
Wenjuan Liu, Robert C. Stanton, Zhaoyun Zhang
Current Opinion in Nephrology & Hypertension (2017) Vol. 26, Iss. 5, pp. 351-357
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top